India To launch Coronavirus Vaccine COVAXIN by August 15

This is as per a letter written as internal communication by ICMR to Bharat Biotech asking for fast-tracking of the indigenous vaccine with an aim to launch by August 15.

COVAXIN™, India’s 1st indigenous Covid-19 vaccine, developed by Bharat Biotech successfully enters human trials.

@ICMRDELHI @DBTIndia @icmr_niv #BharatBiotech #COVAXIN #covid19 #Collaboration #Indiafightscorona #makeinindia #ICMR #coronavirusvaccine pic.twitter.com/MSehntuE8d

— BharatBiotech (@BharatBiotech) June 29, 2020

“It is envisaged to launch the vaccine for public health use latest by 15th August 2020 after completion of all clinical trials. BBIL is working expeditiously to meet the target, however, final outcome will depend on the cooperation of all clinical trial sites involved in this project,” the letter says.PM Modi had recently held a high-level meeting to take stock on the indigenous vaccine efforts.

Reviewed preparations relating to a vaccine to cure COVID-19. An important subject that was discussed was the creation of a tech platform that would complement vaccination at scale across the nation. https://t.co/42hKO0YBof

— Narendra Modi (@narendramodi) June 30, 2020

Bharat Biotech, the company to whom the letter is addressed, has refused to comment on the matter.

ICMR sources confirm the authenticity of the letter but say it was meant for internal communication.

The indigenous vaccine being developed in India is one of the top-priority projects which is being monitored at the top-most level of the government, the statement further read. 

“You have been chosen as a clinical trial site of the BBV152 COVID Vaccine. In view of the public health emergency due to COVID-19 pandemic and urgency to launch the vaccine, you are strictly advised to fast track all approvals related to the initiation of the clinical trial and ensure that the subject enrollment is initiated no later than 7th July 2020,” ICMR’s statement read.

India’s first #COVID19 vaccine candidate, COVAXIN™, gets approval for human trials; it has been jointly developed by @ICMRDELHI , National Institute of Virology (NIV) and Bharat Biotech pic.twitter.com/cd1af5hbus

— DD India (@DDIndialive) June 30, 2020

India has over 6 lakh reported cases of coronavirus with over 18,213 deaths until July 3.